AbbVie’s Blockbuster Vraylar Adds Significant Indication, Adjunctive MDD

 
• By Joseph Haas
  
FDA approved
Adjunctive MDD is Vraylar's fourth US label indication • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip